All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 27, 2022
Home » Blogs » BioWorld MedTech Perspectives

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Abbott Laboratories doubles first quarter device sales with St. Jude deal closure

April 21, 2017
By Stacy Lawrence
No Comments
Abbott Laboratories is aiming to show it's back on track after a turbulent year working toward two major acquisitions. The Abbott Park, Ill.-based company closed its $25 billion purchase of St. Jude Medical Inc. at the start of last quarter, which doubled its medical device sales for the period. It also agreed last week to an amended deal with diagnostics acquisition target Alere, reducing the deal value to $5.3 billion from $5.8 billion; it's slated to close next quarter. With the logistics of the St. Jude and Alere deals largely behind it, Abbott is focused...
Read More

J&J on track to match device industry growth rates in 2018 after restructure

April 20, 2017
By Stacy Lawrence
No Comments
At the start of 2016, Johnson & Johnson (J&J) undertook a massive restructuring aimed at turning around its medical device business. The New Brunswick, N.J., conglomerate has been gradually swapping in high-growth device businesses and ushering out low-growth ones, a disciplined, rational effort that seems to be starting to pay off. During the first quarter, J&J's medical device sales grew by 3 percent to $6.3 billion; that's a marked improvement over the first quarter in 2016 when they shrank by 2.4 percent to $6.1 billion. "Medical devices are about on par now with next year,...
Read More

Cardinal Health to acquire portion of Medtronic's Patient Monitoring & Recovery division for $6.1B

April 19, 2017
By Omar Ford
No Comments
Medtronic plc is set to sell its patient care, deep vein thrombosis and nutritional insufficiency businesses within the Patient Monitoring & Recovery (PMR) division of its Minimally Invasive Therapies Group to Dublin, Ohio-based Cardinal Health Inc. for $6.1 billion. The transaction could close sometime by the end of Medtronic's second fiscal quarter in October. Combined, the businesses expected to be divested in the transaction generated about $2.4 billion in revenue over the last four reported quarters. Among the product lines included in the transaction are the company's dental/animal health, chart paper, wound care, incontinence, electrodes,...
Read More

Myriad study shows discrepancies in Clinvar database for hereditary cancer classification

April 18, 2017
By Omar Ford
No Comments
Public genetic databases could have a discrepancy in identifying BRCA1 and BRCA2 variant classifications, which can introduce uncertainty and diminish patient care, according to a study by Myriad Genetics Inc. and researchers from Gradishar from the Feinberg School of Medicine at Northwestern University. The study was published in this month's edition of the journal The Oncologist and results from it show that the Clinvar public database provided discrepant variant classifications more than 26 percent of the time. The Salt Lake City-based company's study evaluated 4,250 BRCA1 and BRCA2 variants. Clinvar is a freely accessible public...
Read More

Abbott's FDA warning on St. Jude Medical problems could lead to product delays

April 17, 2017
By Stacy Lawrence
No Comments
The FDA issued an April 12 warning letter to Abbott Laboratories regarding known manufacturing and quality control issues that include a long-nagging cybersecurity one. The problems stem from a February inspection of a Sylmar, Calif., facility that was gained via the acquisition of St. Jude Medical, which closed in early January. Abbott Park, Ill.-based Abbott shed more than $1 billion in market cap on the news, with Wall Street analysts worried less about the rectification of these ongoing issues – and more about the potential delays this news could portend for anticipated product approvals, which...
Read More

Philips digital pathology system gets a first FDA nod for primary diagnostic use

April 14, 2017
By Stacy Lawrence
No Comments
Digital slides of patient tissue for pathologists' analysis are ready for the U.S. market. The FDA has issued its first clearance for a whole slide imaging system to enable the review and interpretation of digital surgical pathology slides prepared from biopsied tissue – for Royal Philips' Intellisite Pathology Solution. The agency's decision on the Amsterdam-based company's product was based on one of the largest studies ever done of about 2,000 surgical pathology cases to compare digital pathology to optical microscopes. The FDA clearance includes special controls to ensure the system's precision, reliability and clinical relevance....
Read More

Nanobiosym takes Zika detection mobile with EUA for Gene-Radar diagnostic test

April 13, 2017
By Omar Ford
No Comments
The FDA has issued an emergency use authorization (EUA) for Nanobiosym Diagnostics Inc.'s Gene-Radar Zika virus test. The Cambridge, Mass.-based company's diagnostic is authorized for the qualitative detection of RNA from Zika virus in human serum from individuals meeting Centers for Disease Control and Prevention (CDC) and/or epidemiological criteria by U.S. laboratories. Gene-Radar's EUA comes prior to the summer months where conditions are favorable for mosquitoes that can transmit the Zika virus. There are an estimated 4,800 people infected with Zika in the U.S., with an additional roughly 35,000 in the U.S. territories – primarily...
Read More

Alung closes on $36M series C round as it prepares for a U.S. Hemolung pivotal trial

April 12, 2017
By Omar Ford
No Comments
Alung Technologies Inc. has closed on its $36 million series C financing round that will go toward funding a pivotal trial for the private company's respiratory dialysis technology. The round was led by Royal Philips NV and UPMC, through its innovation and commercialization arm UPMC Enterprises. Other investors include Danvers, Mass.-based Abiomed, The Accelerator Fund, Allos Ventures, Birchmere Ventures, Blue Tree Ventures and Riverfront Ventures. Raymond James & Associates Inc. acted as lead placement agent for the transaction. The Pittsburgh-based company is seeking FDA approval for the Hemolung Respiratory Assist System (RAS), a minimally invasive...
Read More

Neural Analytics raises $10M to market new portable, ultrasound brain monitor

April 11, 2017
By Stacy Lawrence
No Comments
Neural Analytics Inc. raised $10 million to back the commercialization of its portable ultrasound Lucid System that's intended to better enable first responders and health care providers to measure, diagnose and track brain disorders including stroke and traumatic brain injury. The system received FDA clearance last October and a CE mark this January. Part of this financing for the Los Angeles-based start up will also go to back the use of the Lucid system in early diagnostics of brain conditions. In the future, Neural Analytics plans upgrades to its technology to include robotics that obviate...
Read More

Electrical implants enable paralyzed man to move his limb in feasibility study

April 10, 2017
No Comments
Technology to enable paralyzed patients to move, and even to feel, their limbs is advancing apace. The latest progress comes from Case Western Reserve University researchers who have worked for months with a man with quadriplegia to enable him to raise a mug to his own lips to sip through a straw. He made the movement simply through his thoughts due to temporarily implanted, linked brain-recording and muscle-stimulating systems. It took four months of practice with a virtual arm on a computer screen and 45 weeks of physical training for his arm and shoulder to...
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 50 51 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 27, 2022.
  • China U.S. deal

    Merck acquires global rights to cancer drug from Kelun in $1.4B deal

    BioWorld
    In a deal potentially worth more than $1.4 billion, Sichuan Kelun Pharmaceutical Co. Ltd. has out-licensed a large molecule drug in cancer to Merck & Co. Inc. for...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for May 27.
  • Lung cancer illustration

    Acea Pharma fails to win green light for abivertinib in China

    BioWorld
    Zhejiang Acea Pharmaceutical Co. Ltd. failed to obtain marketing approval from China’s NMPA for its third-generation EGFR tyrosine kinase inhibitor, abivertinib....
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing